QuidelOrtho Reports 3Q 2024 Financial Results
November 08, 2024
November 08, 2024
SAN DIEGO, California, Nov. 8 -- Quidel Corp., a provider of in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, issued the following news release on Nov. 7, 2024:
* * *
- Company reinstates 2024 financial guidance -
- Drives cost-savings and growth initiatives -
- Strengthens leadership team and aligns organization for improved effectiveness -
Third Quarter 2024 Results and . . .
* * *
- Company reinstates 2024 financial guidance -
- Drives cost-savings and growth initiatives -
- Strengthens leadership team and aligns organization for improved effectiveness -
Third Quarter 2024 Results and . . .